immuno-PET

You have access
⁸⁹Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
Kyung-Ho Jung, Jin Won Park, Jin Hee Lee, Seung Hwan Moon, Young Seok Cho and Kyung-Han Lee

Journal of Nuclear Medicine May 10, 2021, 62 (5) 656-664; DOI: https://doi.org/10.2967/jnumed.120.250720
You have access
Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer
Kelly E Henry, Travis Shaffer, Kyeara N Mack, Janine Ring, Anuja Ogirala, Susanne Klein-Scory, Christina Eilert-Micus, Wolff Schmiegel, Thilo Bracht, Barbara Sitek, Marguerite Clyne, Colm Reid, Bence Sipos, Jason S. Lewis, Holger Kalthoff and Jan Grimm

Journal of Nuclear Medicine March 12, 2021, jnumed.120.256776; DOI: https://doi.org/10.2967/jnumed.120.256776
Open Access
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
Patricia M.R. Pereira, Jalen Norfleet, Jason S. Lewis and Freddy E. Escorcia

Journal of Nuclear Medicine March 1, 2021, 62 (3) 366-371; DOI: https://doi.org/10.2967/jnumed.120.244897
You have access
Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
caroline bodet-milin, Alain faivre-chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, delphine Drui, David M Goldenberg, Robert M Sharkey, Jacques Barbet and Francoise Kraeber-Bodere

Journal of Nuclear Medicine February 5, 2021, jnumed.120.252791; DOI: https://doi.org/10.2967/jnumed.120.252791
You have access
Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
Philipp Diebolder, Cedric Mpoy, Jalen Scott, Truc T. Huynh, Ryan Fields, Dirk Spitzer, Nilantha Bandara and Buck E. Rogers

Journal of Nuclear Medicine January 1, 2021, 62 (1) 137-143; DOI: https://doi.org/10.2967/jnumed.120.249557
You have access
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
Caroline Rousseau, David M. Goldenberg, Mathilde Colombié, Jean-Charles Sébille, Philippe Meingan, Ludovic Ferrer, Pierre Baumgartner, Evelyne Cerato, Damien Masson, Mario Campone, Aurore Rauscher, Vincent Fleury, Catherine Labbe, Alain Faivre Chauvet, Jean-Sebastien Fresnel, Claire Toquet, Jacques Barbet, Robert M. Sharkey, Loic Campion and Françoise Kraeber-Bodéré

Journal of Nuclear Medicine August 1, 2020, 61 (8) 1205-1211; DOI: https://doi.org/10.2967/jnumed.119.236000
You have access
Light-Induced Radiosynthesis of ⁸⁹Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor
Simon Klingler, Rachael Fay and Jason P. Holland

Journal of Nuclear Medicine July 1, 2020, 61 (7) 1072-1078; DOI: https://doi.org/10.2967/jnumed.119.237180
You have access
Total-Body PET and Highly Stable Chelators Together Enable Meaningful ⁸⁹Zr-Antibody PET Studies up to 30 Days After Injection
Eric Berg, Herman Gill, Jan Marik, Annie Ogasawara, Simon Williams, Guus van Dongen, Daniëlle Vugts, Simon R. Cherry and Alice F. Tarantal

Journal of Nuclear Medicine March 1, 2020, 61 (3) 453-460; DOI: https://doi.org/10.2967/jnumed.119.230961
You have access
⁸⁹Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber and Marc C. Huisman

Journal of Nuclear Medicine December 1, 2019, 60 (12) 1825-1832; DOI: https://doi.org/10.2967/jnumed.118.224568
You have access
A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for ¹⁸F-Immuno-PET and Fluorescence Imaging
Kirstin A. Zettlitz, Christopher M. Waldmann, Wen-Ting K. Tsai, Richard Tavaré, Jeffrey Collins, Jennifer M. Murphy and Anna M. Wu

Journal of Nuclear Medicine October 1, 2019, 60 (10) 1467-1473; DOI: https://doi.org/10.2967/jnumed.118.223560

Main menu

User menu

Search

immuno-PET

Pages